Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,671 shares at $17.56 ($64K) on 2025-03-25, disclosed to the SEC on 2025-03-26.
Scheduled sale ($64k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.52 | 1,500 | $26K | 40.8% |
| 2 | $17.56 | 2,171 | $38K | 59.2% |
| Total | $17.54 avg | 3,671 | $64K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |
| ARQT | SELL | 2024-12-23 | $228K | — | Filing → |